Latest News

Carevive has won the first Pfizer Patient Reported Outcomes Challenge

Debiopharm invests in DTx leader Voluntis

BC Platforms Partners with CO-CONNECT Consortium to accelerate COVID-19 research

Immunexpress’ rapid test for sepsis launched in Europe on Biocartis’ Idylla platform

Debiopharm co-leads an investment round of €10 million in Oncomfort

Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation to further develop…

Nucleai Secured $6.5m Series-A Initial Closing Led by Debiopharm to Advance Ai-Powered Precision Oncology Platform

Debiopharm invests in NucleAI– using AI to develop digital pathology biomarkers

Immunexpress awarded funding to develop their COVID-19 patient triage test SeptiCyte® RAPID